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Preceptor: Dr. Barbara Dalton
1
Lyme Disease: Confusing Tests; 
Confused Patients
• Even without diving into the scourge of “chronic Lyme,” 
understanding the diagnosis and treatment of Lyme disease 
can be difficult for patients and healthcare providers alike
• The two-step testing recommended by the CDC may not seem 
straightforward without some understanding of:
– What is being analyzed in the blood sample
– Why the sensitivity/specificity of these tests is important
• Many of the resources available to patients and healthcare 
providers are either too technical or too basic
• No single resource was identified that provided enough detail 
without becoming too confusing
2
The Cost of Tests and Medications
• One retrospective cohort study found that in California <20% 
of all tests for Lyme disease were ordered because the disease 
was actually suspected in the patient.1
– 35% were requested by the patient based on undue clinical suspicion
– 41% were ordered as part of “screening tests” for nonspecific findings
• A study at Yale found that of ~200 patients referred for the 
presumptive diagnosis of Lyme disease >60% had no evidence 
of current or past infection yet had received an average of:3
– 4 serologic tests
– 7 office visits relating to Lyme disease
– 42 days of antibiotics
– 1 death related to inappropriate treatment4
• While no research has shown resource overutilization in 
Vermont, subjective evidence from clinicians is abundant 3
Community Perspectives
• JD (anonymized) presented to the clinic after being diagnosed 
with “chronic Lyme” at a holistic health center
– She was placed on a “Lyme diet” of red meat and berries that was 
giving her diarrhea and making her feel “awful”
– She claimed that her ELISA results were “equivocal,” was told that she 
“definitely had chronic Lyme disease”
– She didn’t understand what the test results meant and didn’t 
understand what the test was even analyzing
• Victoria Sheehan, a staff nurse at the clinic, expressed some 
frustration with explaining intricacies/complexities of Lyme 
testing to patients during triage5
– Details of IgM/IgG seroconversion and duration of immune response
– When re-testing is indicated and if previous exposure = false positive
– What duration of tick bite warrants testing
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How Can We Help?
• Educating patients and clinicians about the recommended 
guidelines for testing, interpretation of test results, and the 
basic-science immunology behind Lyme disease may prove to 
be an inexpensive and easy intervention
• An educational document for use as an in-office guide and 
digital distribution was created using simple language to 
illustrate the sometimes complex concepts of:
– The CDC’s testing guidelines for when Lyme disease is suspected
– The rationale behind two-tier testing relating to sensitivity/specificity
– The roles/time-course of IgM and IgG in of Lyme disease
• The hope is that this document can be distributed or referred 
to as a starting point for any conversations concerning the 
sometimes confusing diagnosis of Lyme disease
5
Patient and Clinician Response
• Subjective responses from patients presented with 
information related to the previously mentioned education 
goals were positive:
– “I never new any of this before. I wish someone had just taken the 
time to explain it to me.”
– “I know that I shouldn’t trust all the crap on the internet… This makes 
a lot more sense.”
• Clinicians, unfortunately, didn’t have the opportunity to 
present any of the information to patients face-to-face or via 
phone triage, but thought that “it could be really helpful 
when I’m trying to jump between calls of a pregnant lady 
bleeding and someone who thinks that they maybe might 
have found a tick on their leg.” 
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Effectiveness and Limitations
• The educational document explains testing guidelines into 
easy to understand pieces with accompanying visual guides
– One page (front and back) provides a single discrete page that can be 
distributed to patients and easily referred to
– Digital format allows for distribution to patients during phone triage
– Document addresses common concerns raised by clinicians and 
patients
• The document does not cover all concerns that might be 
raised by patients
– Much of the complexity and subtlety of testing can not/was not 
conveyed given the length/wording of the document
– “Chronic Lyme Disease” was found to be a very common concern 




• Keep the document in digital form to allow for easy updating 
if there are any changes in testing guidelines
• While this document does a good job of covering information 
in an appropriate level of depth it is not especially pretty and 
could use additional work to allow for greater legibility
• Create a separate document to cover “Chronic Lyme Disease”
– Major area of concern to many patients
– Sometimes very difficult to talk about with patients
– Information to act as a starting point for conversations with patients
• Receive more feedback that might be used to further update 
the document to ensure that it covers key areas of concern to 
patients that it might currently be missing
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